Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Celgene Corporation
3108
Celgene Corporation
Health Care
Medical
Technology
Biotechnology
Global biopharmaceutical company. Tweets by Greg Geissman & Julissa Viana. Review our guidelines on our site
Suggest edits
Founded
1986
Follow us
Companies in the same industry
SetPoint Medical
Alexion Pharmaceuticals, Inc.
UniQure
molecular assemblies
Dynamic Code
EternoGen
Gloucester Pharmaceuticals
Batu Biologics
Thermosome
ID Genomics
Alexa global traffic share
Twitter followers
Overview
Investments
36
Acquisitions
9
Apps
6
Add info
Team Size
5000+
Employees
I work here
Location
United States
Headquarters
Explore United States
Xconomy
Anemia Drug From Acceleron Pharma and Celgene Wins FDA Approval
Xconomy
,
Reuters Top News
Celgene to Sell Blockbuster Drug to Amgen for $13B to Close BMS Deal
MedCity News
Celgene filing plans potentially mean two more CAR-Ts on the market by end of next year
Reuters Top News
,
GeekWire
Bristol-Myers plans to divest Celgene's psoriasis drug
Xconomy
Thwarting Opposition, Bristol Gets Shareholder OK for $74B Celgene Buyout
Xconomy
Amid Acquisition Drama, Celgene Resubmits MS Drug for FDA Approval
Xconomy
The Life, Troubles, and Celgene Legacy of Deal Guru George Golumbeski
Reuters Top News
,
MedCity News
Starboard joins opposition to Bristol-Myers' $74 billion Celgene deal
Reuters Top News
Top Bristol-Myers shareholder comes out against $74 billion Celgene...
Xconomy
Bristol-Myers’ $74B Celgene Buyout Faces Opposition from Wellington
Xconomy
Starboard Ups Bristol-Myers Stake Ahead of Vote on Celgene Deal
Xconomy
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
Robotics
GeekWire
Bristol-Myers Squibb’s $74B acquisition of Juno parent Celgene puts Seattle biotech world on alert
Gründerszene
Bristol-Myers will Celgene für 74 Milliarden US-Dollar kaufen
MedCity News
Bristol-Myers Squibb to acquire Celgene in $74B deal
Xconomy
Celgene Doubles Down on Dragonfly, Pays $50M to Expand Cancer Pact
$9,000,000,000
GeekWire
Longtime Juno Therapeutics CEO Hans Bishop leaves role after merger with Celgene
Strategy
Health
Bloomberg
People Are Talking About a Celgene LBO; That Should Worry It
Health
Stock markets
Bloomberg
Celgene's Execution Problems Are Beyond the Pale
Health
GeekWire
Why Celgene decided to buy Juno Therapeutics for $9B — with a little help from U.S. tax reform
Health
